Skorpios Trust - Dec 23, 2024 Form SCHEDULE 13D/A Schedule Report for Stoke Therapeutics, Inc. (STOK)

Filing Manager
Skorpios Trust
Reporting Manager
Skorpios Trust
Security
Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
STOK
Shares outstanding
53.1M shares
Disclosed Ownership
6.91M shares
Ownership
13%
Form type
SCHEDULE 13D/A
Date filed
12/27/2024, 05:23 PM
Date of event
Dec 23, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Blue Horizon Enterprise Ltd. 5.6% 2.97M 0 2.97M /s/ Eleni Constantinon Kyriacou Eleni Constantinon Kyriacou, Director
Ezbon International Limited 7.4% 3.94M 0 3.94M /s/ Eleni Constantinon Kyriacou Eleni Constantinon Kyriacou, Director
Montrago Trustees Limited 13% 6.91M 0 6.91M /s/ Androulla Papadopoulou Androulla Papadopoulou, Director
Skorpios Trust 13% 6.91M 0 6.91M /s/ Androulla Papadopoulou Androulla Papadopoulou, Director 0001869333